Fluvoxamine
Showing 26 - 50 of 133
OCD Trial in Hamilton (SSRIs)
Completed
- Obsessive-Compulsive Disorder
-
Hamilton, Ontario, CanadaMacAnxiety Research Centre
Aug 31, 2020
OCD, Anxiety Disorders, Mental Disorders Trial in Shanghai (Fluoxetine, Sertraline, Paroxetine)
Completed
- Obsessive-Compulsive Disorder
- +2 more
- Fluoxetine
- +5 more
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Aug 12, 2020
Depression Trial (Fecal microbiota transplantation(FMT), Placebo)
Not yet recruiting
- Depression
- Fecal microbiota transplantation(FMT)
- Placebo
- (no location specified)
May 6, 2023
OCD Trial in Shanghai (Mindfulness-based Cognitive Therapy, Psycho-education Program, sertraline, fluvoxamine)
Completed
- Obsessive-Compulsive Disorder
- Mindfulness-based Cognitive Therapy
- +2 more
-
Shanghai, Shanghai, ChinaClinical psychiatrist
Jan 5, 2020
OCD Trial in Shanghai (behavioral, drug, other)
Completed
- Obsessive-Compulsive Disorder
- cognitive behavioral group therapy
- +2 more
-
Shanghai, Shanghai, ChinaClinical psychiatrist
Jan 5, 2020
PTSD, Depression, Alcohol-Related Disorders Trial in United States (Motivational Interviewing, Cognitive Behavioral Therapy
Completed
- Posttraumatic Stress Disorder
- +10 more
- Motivational Interviewing
- +13 more
-
Scottsdale, Arizona
- +23 more
Jul 1, 2021
Pharmacology, Clinical, Healthy Trial in Madison (Pomalidomide, Ketoconazole, Fluvoxamine)
Completed
- Pharmacology, Clinical
- Healthy
- Pomalidomide
- +3 more
-
Madison, WisconsinCovance Research Unit, Inc
Nov 7, 2019
Taste Supra-thresholds AmongSample of Depressed Egyptian Adult
Completed
- Taste Disorders
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Feb 2, 2022
MDD Trial in Shanghai (SSRIs, SSRI plus Sulforaphane)
Recruiting
- Major Depressive Disorder
- SSRIs
- SSRI plus Sulforaphane
-
Shanghai, ChinaShanghai Mental Health Center
Dec 6, 2021
Dermatitis, Atopic Trial in Brussels (Period 1 - Day 1: PF-04965842 administered, Period 2: Cohort 1: Fluvoxamine & PF-04965842,
Completed
- Dermatitis, Atopic
- Period 1 - Day 1: PF-04965842 administered
- +2 more
-
Brussels, BelgiumPfizer Clinical Research Unit
Jan 29, 2019
Gustatory Modulators AmongSample of Depressed Egyptian Adults
Completed
- Taste Disorders
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Jun 13, 2021
Prediction of Adolescents With MDD Response to ECT Via MRI
Recruiting
- Major Depressive Disorder
- +2 more
- Modified Electroconvulsive Therapy
- Conventional pharmacotherapy
-
Chongqing, Province, ChinaThe First Affiliated Hospital of Chongqing Medical University
May 26, 2023
Social Anxiety Disorder Trial in New York (Cariprazine, Placebo)
Not yet recruiting
- Social Anxiety Disorder
- Cariprazine
- Placebo
-
New York, New YorkThe Medical Research Network, LLC
May 17, 2022
Treatment Resistant MDD Trial in Canada, United States (Aripiprazole, Repetitive transcranial magnetic stimulation (rTMS),
Completed
- Treatment Resistant Major Depressive Disorder
- Aripiprazole
- +2 more
-
Birmingham, Alabama
- +12 more
Apr 26, 2022
Depression in Adolescence Trial in Calgary (Pharmacogenetic-guided dosing, GLAD-PC guided dosing)
Not yet recruiting
- Depression in Adolescence
- Pharmacogenetic-guided dosing
- GLAD-PC guided dosing
-
Calgary, Alberta, CanadaUniversity of Calgary
Jul 25, 2023
MRS and Medication Response: A Pilot Study
Terminated
- Major Depressive Disorder
- +5 more
-
Stanford, CaliforniaStanford University Psychiatry and Biobehavioral Sciences
Aug 12, 2021
Uremic Pruritis Trial in Alexandria (sertraline, )
Completed
- Uremic Pruritis
- sertraline
- placebo
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Dec 12, 2022
Gustatory Dysfunction AmongSample of Depressed Egyptian Adults
Completed
- Taste Disorders
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Jan 29, 2021
Bipolar Disorder, Anxiety Disorders, Anxiety Trial in Pittsburgh (Inositol)
Not yet recruiting
- Bipolar Disorder
- +2 more
-
Pittsburgh, PennsylvaniaChild and Adolescent Bipolar Services-WPIC Bellefield
Dec 2, 2022
MDD Trial in Chengdu (HS-10353, Placebo)
Enrolling by invitation
- Major Depressive Disorder
- HS-10353
- Placebo
-
Chengdu, Sichuan, ChinaWest China Hospital
Jan 13, 2022
Delirium Trial in Providence (Ramelteon, Placebo - Cap)
Completed
- Delirium
- Ramelteon
- Placebo - Cap
-
Providence, Rhode IslandRhode Island Hospital
Mar 14, 2022
Bupivacaine Levels in Liver Resection Patients
Completed
- Hepatectomy
- Analgesia, Epidural
-
Kingston, Ontario, CanadaKingston General Hospital
Jul 29, 2021
Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)
Recruiting
- Fibrotic Pulmonary Sequelae Post-COVID19 Infection
- Pirfenidone
- Placebo
-
Hospitalet de Llobregat, Barcelona, Spain
- +7 more
Dec 29, 2021